UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis

BMC cancer, 2024-02, Vol.24 (1), p.188-188, Article 188

2024

Volltextzugriff (PDF)

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma

Frontiers in oncology, 2022-12, Vol.12, p.953671-953671

2022

Volltextzugriff (PDF)

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

BMC cancer, 2024-02, Vol.24 (1), p.186-186, Article 186

2024

Volltextzugriff (PDF)

A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer

Frontiers in immunology, 2022-10, Vol.13, p.948597-948597

2022

Volltextzugriff (PDF)

Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysis

Frontiers in oncology, 2024-07, Vol.14, p.1293598

2024

Volltextzugriff (PDF)

Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

BMC public health, 2023-08, Vol.23 (1), p.1531-1531, Article 1531

2023

Volltextzugriff (PDF)

A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases

Frontiers in pharmacology, 2024-07, Vol.15, p.1374136

2024

Volltextzugriff (PDF)

Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis

Frontiers in pharmacology, 2023-03, Vol.14, p.1119906

2023

Volltextzugriff (PDF)

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial

Frontiers in medicine, 2022-08, Vol.9, p.938940-938940

2022

Volltextzugriff (PDF)

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis

Frontiers in pharmacology, 2022-09, Vol.13, p.910656-910656

2022

Volltextzugriff (PDF)

Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model

Frontiers in public health, 2023-02, Vol.11, p.1051484-1051484

2023

Volltextzugriff (PDF)

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China

Frontiers in public health, 2022-08, Vol.10, p.912921-912921

2022

Volltextzugriff (PDF)

A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer

BMC medicine, 2024-01, Vol.22 (1), p.13-17, Article 13

2024

Volltextzugriff (PDF)

Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective

Cost effectiveness and resource allocation, 2024-09, Vol.22 (1), p.70-11, Article 70

2024

Volltextzugriff (PDF)

Adverse outcomes of artificial pneumothorax under right bronchial occlusion for patients with thoracoscopic-assisted oesophagectomy in the prone position versus the semiprone position

Frontiers in oncology, 2022-08, Vol.12, p.919910-919910

2022

Volltextzugriff (PDF)

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis

Frontiers in public health, 2022-04, Vol.10, p.869960-869960

2022

Volltextzugriff (PDF)

Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

Cost effectiveness and resource allocation, 2023-11, Vol.21 (1), p.1-80, Article 80

2023

Volltextzugriff (PDF)

Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective

Frontiers in public health, 2023-09, Vol.11, p.1282374-1282374

2023

Volltextzugriff (PDF)

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China

Frontiers in public health, 2022-08, Vol.10, p.952378-952378

2022

Volltextzugriff (PDF)

Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysis

Frontiers in surgery, 2023-02, Vol.10, p.1090233-1090233

2023

Volltextzugriff (PDF)

Traffic Flow Prediction and Analysis in Smart Cities Based on the WND-LSTM Model

Computational intelligence and neuroscience, 2022-08, Vol.2022, p.1-9

2022

Volltextzugriff (PDF)

Relay selection and power allocation for spectrum leasing in cooperative cognitive radio networks

2017 36th Chinese Control Conference (CCC), 2017, p.8958-8963

2017

Volltextzugriff (PDF)

Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

BioDrugs : clinical immunotherapeutics, biopharmaceuticals, and gene therapy, 2023-05, Vol.37 (3), p.421-432

2023

Volltextzugriff (PDF)

Sotorasib versus Docetaxel for treatment of US and Chinese patients with advanced non-small-cell lung cancer with KRAS p.G12C-mutated: A cost-effectiveness analysis to inform drug pricing

Medicine (Baltimore), 2023-12, Vol.102 (50), p.e36387-e36387

2023

Volltextzugriff (PDF)

Subchannel and resource allocation in cognitive radio sensor network with wireless energy harvesting

Computer networks (Amsterdam, Netherlands : 1999), 2020-02, Vol.167, p.107028, Article 107028

2020

Volltextzugriff (PDF)

1 – 25 von 113

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(104)

Publikationsform

Sprache

Englisch
(113)

Erscheinungsjahr

n.n

Thema

Science & Technology
(90)
Life Sciences & Biomedicine
(41)
Technology
(34)
Materials Science
(20)
Physical Sciences
(18)
Humans
(17)
Engineering
(15)
Materials Science, Multidisciplinary
(15)
Science & Technology - Other Topics
(14)
Oncology
(11)
Physics
(11)
Chemistry
(10)
Engineering, Electrical & Electronic
(9)
Network Meta-Analysis
(9)
Patients
(9)
Cancer Therapies
(8)
Cost-Effectiveness Analysis
(8)
Public Health
(8)
Public, Environmental & Occupational Health
(8)
Cost-Benefit Analysis
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis

Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma

Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis

A systematic review and network meta-analysis of first-line immune checkpoint inhibitor combination therapies in patients with advanced non-squamous non-small cell lung cancer

Comparison of systemic treatments for previously treated patients with unresectable colorectal liver metastases: a systematic review and network meta-analysis

Cost-effectiveness and potential budget impact of non-pharmacological interventions for early management in prehypertensive people: an economic evaluation for China

A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases

Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis

The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis

Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model

Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China

A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer

Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective

Adverse outcomes of artificial pneumothorax under right bronchial occlusion for patients with thoracoscopic-assisted oesophagectomy in the prone position versus the semiprone position

Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis

Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method

Cost-effectiveness analysis of atezolizumab in patients with non-small-cell lung cancer ineligible for treatment with a platinum-containing regimen: a United Kingdom health care perspective

Cost-effectiveness analysis of colonoscopy and fecal immunochemical testing for colorectal cancer screening in China

Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysis

Traffic Flow Prediction and Analysis in Smart Cities Based on the WND-LSTM Model

Relay selection and power allocation for spectrum leasing in cooperative cognitive radio networks

Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing

Sotorasib versus Docetaxel for treatment of US and Chinese patients with advanced non-small-cell lung cancer with KRAS p.G12C-mutated: A cost-effectiveness analysis to inform drug pricing

Subchannel and resource allocation in cognitive radio sensor network with wireless energy harvesting

Suchergebnisse filtern